Sanofi-Aventis U.S., LLC v. Dr. Reddy’s Labs., Inc.

Published date20 November 2019
Subject MatterFDA,Patents,Hatch-Waxman,Obviousness,Mootness,Prescription Drugs,Patent Trial and Appeal Board,Generic Drugs,Patent-in-Suit,Patent Litigation,Pharmaceutical Patents,Patent Infringement,Sanofi-Aventis,Intellectual Property Protection,Pharmaceutical Industry,Inter Partes Review (IPR) Proceeding,Dr. Reddy’s Labs.
AuthorJeffrey Alan Hovden,Oren Langer,Andrew Kabat,Christopher Pinahs,Kelsey McElveen
Law FirmRobins Kaplan LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT